Name : APOBEC3C Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN4359726820
| Long name | APOBEC3C Primary Polyclonal Antibody |
| Also known as | APOBEC3C PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | APOBEC3C |
| Specificity | This is a highly specific antibody against APOBEC3C |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human APOBEC3C |
| Gene ID number | 27350 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | APOBEC3F deaminates deoxycytosine to deoxyuracil in the minus strand of HIV-1 DNA, APOBEC3G and APOBEC3F provide a mechanism for innate immunity to retroviruses, HIV-1 Vif cannot form a complex with APOBEC3G or APOBEC3F of mouse origin as it does with the human protein, Interestingly, Like APOBEC3G, The seven APOBEC3 genes or pseudogenes are found in a cluster thought to result from gene duplication on chromosome 22, This implies that induction of APOBEC3G and APOBEC3F activity or a method of blocking their interaction with Vif may provide a method for therapeutic intervention, Thus, Viral infectivity factor (Vif) imparts APOBEC3G and APOBEC3F resistance to HIV through impaired translation of their mRNA and accelerated posttranslational degradation of the APOBEC3 proteins by the 26S proteasome, and are also likely contribute to sequence variation observed in many viruses, and thus mouse APOBEC3G and APOBEC3F function as a potent inhibitors of wildtype HIV-1 replication, resulting in G to A hypermutation in the plus strand of DNA, where human APOBEC3G and APOBEC3F are only able to inhibit Vif-deficient HIV-1 replication, APOBEC proteins inhibit retroviruses by deaminating cytosine residues of viral RNA and DNA |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | APOBEC1 like, APOBEC1-like, APOBEC1L, APOBEC3C, ARDC2, ARDC4, ARP5, Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 3C, MGC19485, PBI, Phorbolin I, Phorbolin I protein, Probable DNA dC dU editing enzyme APOBEC 3C, Probable DNA dC->, bK150C2, 3, ABC3C_HUMAN, dU-editing enzyme APOBEC-3C |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | APOBEC3C |
| Short name | APOBEC3C Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | APOBEC3C (Antibody to) |
| Alternative technique | antibodies |
| Identity | 17353 |
| Gene | APOBEC3C |
| Long gene name | apolipoprotein B mRNA editing enzyme catalytic subunit 3C |
| Synonyms gene name | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C |
| Synonyms | APOBEC1L PBI bK150C2, 3 ARDC2 ARDC4 ARP5 |
| Locus | 22q13, 1 |
| Discovery year | 2001-12-12 |
| GenBank acession | AF165520 |
| Entrez gene record | 27350 |
| Pubmed identfication | 11863358 |
| RefSeq identity | NM_014508 |
| Classification | Apolipoprotein B mRNA editing enzyme catalytic subunits |
| Havana BLAST/BLAT | OTTHUMG00000151087 |